P&R — Market Access

Pricing & Reimbursement for the Benelux Market

Pharmaceutical companies must deal with a continuously growing number of regulations and requirements. To bring mature and new medicinal products to patients rapidly, a focused and transparent market access strategy is a must. M.P.C.A. International is specialised in market access in the Benelux for pharmaceuticals and medical devices.

Benelux market access specialists
National pricing dossier preparation & filing
Reimbursement submissions
Extensive network of leading therapeutic area experts
Market access services

Our pricing & reimbursement service areas

Through our extensive network, we work with leading experts in all important strategic therapeutic areas to build market access strategies that enable faster patient access.

Strategic Counselling

We guide clients to the best market access route and pricing strategy. We build market access strategies enabling faster patient access to therapies, tailored to the specific Benelux regulatory and reimbursement environment.

Price Determination

We prepare and file national pricing dossiers. We set prices for optimal access and returns according to economic and international criteria, ensuring competitive positioning and compliance with local pricing regulations.

Reimbursement

We prepare and file reimbursement dossiers, navigating the complex requirements of Belgian, Dutch and Luxembourg reimbursement authorities to maximise patient access and ensure optimal reimbursement conditions.

Governmental affairs

Creating a favourable market environment

We create a favourable environment in which companies can dedicate their treatments for patients globally, through strategic governmental and public affairs across the Benelux.

Through our extensive network and deep understanding of the Benelux regulatory and political landscape, we advocate for conditions that support faster market access and optimal reimbursement for your products.

Discuss your market access strategy

Governmental affairs goals

Shortening duration for market access

Improving reimbursement conditions

Ensuring best pricing conditions

Faster patient access to therapies

Frequently asked questions

Pricing & Reimbursement

What is pricing and reimbursement in the pharmaceutical sector?
Pricing and reimbursement refers to the processes by which the price of a medicine is set and by which it becomes eligible for reimbursement by the national health system. Securing a favourable price and reimbursement status is essential for patient access to a product.
How does M.P.C.A. International support market access?
We provide strategic market access counselling for the Benelux, including pricing and reimbursement dossier preparation and governmental affairs, to optimise patient access to your product.
In which countries do you provide pricing and reimbursement support?
We support pricing and reimbursement in the Benelux (Belgium, the Netherlands and Luxembourg) taking into account the specific national procedures and authorities in each country.
How do I start a pricing and reimbursement project?
You can contact our team for a consultation. We assess your product and propose a tailored market access strategy for the Benelux.
Get in touch

Ready to define your Benelux market access strategy?

Our market access specialists will help you navigate the Benelux pricing and reimbursement landscape, ensuring faster patient access and optimal returns.